A unique piece of news has been spreading over the past 48 hours, all about ‘three-parent’ babies born after a medical breakthrough. This remarkable advancement in medical science has led to the birth of eight healthy babies in the United Kingdom using a technique that involves DNA from three individuals—their mother, father, and a donor who provides healthy mitochondrial DNA. This innovative approach was developed to help mothers with mitochondrial disease avoid passing on serious genetic disorders. Researchers involved in the trial have confirmed that all eight babies are doing well.
What are ‘three-parent’ Babies?
‘Three-parent’ babies are born using a special technique called mitochondrial donation, designed to prevent inherited mitochondrial diseases. This advanced IVF method involves DNA from three individuals—the mother, the father, and a healthy female donor. While the baby inherits nuclear DNA (which determines traits like eye colour and height) from the mother and father, a small amount of mitochondrial DNA (less than 1%) comes from the donor. Mitochondria are energy-producing structures in cells, and defects in them can cause serious disorders. This technique ensures the baby is free from such conditions while retaining the biological identity of the parents.
Also Read: Why Some Babies Walk Sooner: New Study Finds Genetic Clues Behind Baby’s First Steps
The Story of Three-Parent Babies
The concept of a “three-parent baby” emerged from efforts to prevent the transmission of inherited mitochondrial diseases, which are passed down from mother to child. The breakthrough came in the early 2010s with the development of mitochondrial donation techniques like maternal spindle transfer and pronuclear transfer.
In 2016, the world’s first confirmed birth of a three-parent baby took place in Mexico. An American medical team, led by Dr. John Zhang, used the maternal spindle transfer technique to help a Jordanian couple whose previous children had died from Leigh syndrome, a severe mitochondrial disorder. The procedure was performed in Mexico to bypass legal restrictions in the United States.
The United Kingdom became the first country to officially legalize mitochondrial donation in 2015, under strict regulations. In 2023, the UK’s Human Fertilisation and Embryology Authority (HFEA) confirmed that several babies had been born using this technique.
The procedure involves replacing faulty mitochondria in a mother’s egg with healthy mitochondria from a female donor, ensuring the baby inherits nuclear DNA from both biological parents and mitochondrial DNA from the donor.
Current Status of Technique
As of 2025, the UK leads in mitochondrial donation, with eight babies born through this technique under strict regulation. The Human Fertilisation and Embryology Authority oversees the process, with around 35 procedures approved. Australia legalized the method under Maeve’s Law in 2022, with clinical trials expected to start by 2026.
In contrast, countries like the United States and Canada prohibit clinical use due to laws banning heritable genetic modification. In Greece, Mexico, and Ukraine, the technique has been used experimentally, often for fertility rather than disease prevention.
Globally, adoption remains limited due to ethical, legal, and religious concerns, but the technique shows growing promise for families affected by mitochondrial disorders.
Future of Mitochondrial Donation
The future of mitochondrial donation holds promise, but its progress will depend on careful navigation of ethical, regulatory, and religious considerations. While scientific advances continue to improve safety and expand potential applications, including treatment-resistant infertility, broader acceptance will require clear legal frameworks and public trust. Ethical debates around genetic modification and the involvement of a third genetic contributor remain sensitive, particularly in societies with strong religious values. Countries like the UK and Australia offer structured models, but others remain cautious. As awareness and understanding grow, global dialogue involving scientists, ethicists, regulators, and faith communities will be essential to shape the responsible and inclusive use of this technology.
